Does increased levetiracetam clearance during pregnancy require planned intervention?
作者信息
Abou-Khalil Bassel W
出版信息
Epilepsy Curr. 2008 May-Jun;8(3):62-3. doi: 10.1111/j.1535-7511.2008.00238.x.
Abstract
摘要
相似文献
1
Does increased levetiracetam clearance during pregnancy require planned intervention?
Epilepsy Curr. 2008 May-Jun;8(3):62-3. doi: 10.1111/j.1535-7511.2008.00238.x.
2
Increased levetiracetam clearance associated with a breakthrough seizure in a pregnant patient receiving once/day extended-release levetiracetam.
Pharmacotherapy. 2014 Jul;34(7):e128-32. doi: 10.1002/phar.1439. Epub 2014 May 7.
3
Levetiracetam use in pregnancy.
Ann Pharmacother. 2009 Oct;43(10):1692-5. doi: 10.1345/aph.1M231. Epub 2009 Aug 18.
4
Levetiracetam plasma level monitoring during pregnancy, delivery, and postpartum: clinical and outcome implications.
Epilepsy Behav. 2009 Jul;15(3):372-5. doi: 10.1016/j.yebeh.2009.04.006. Epub 2009 May 27.
5
Therapeutic Drug Monitoring of Levetiracetam in Select Populations.
J Pharm Pharm Sci. 2018;21(1s):149s-176s. doi: 10.18433/jpps30081.
6
Age and comedications influence levetiracetam pharmacokinetics in children.
Pediatr Neurol. 2010 Oct;43(4):231-5. doi: 10.1016/j.pediatrneurol.2010.05.008.
7
Treatment of Juvenile Myoclonic Epilepsy in Patients of Child-Bearing Potential.
CNS Drugs. 2019 Mar;33(3):195-208. doi: 10.1007/s40263-018-00602-2.
8
Effect of Levetiracetam on Time to High-Dose Methotrexate Clearance in Patients With Hematologic Malignancies.
J Clin Pharmacol. 2020 Mar;60(3):324-330. doi: 10.1002/jcph.1544. Epub 2019 Nov 14.
9
Levetiracetam safety profiles and tolerability in epilepsy patients.
Expert Opin Drug Saf. 2004 Sep;3(5):415-24. doi: 10.1517/14740338.3.5.415.
10
Fetal safety of levetiracetam use during pregnancy.
Acta Neurol Belg. 2018 Sep;118(3):503-508. doi: 10.1007/s13760-018-0996-7. Epub 2018 Jul 28.
本文引用的文献
1
Plasma concentrations of lamotrigine and its 2-N-glucuronide metabolite during pregnancy in women with epilepsy.
Epilepsia. 2008 Jun;49(6):1075-80. doi: 10.1111/j.1528-1167.2007.01471.x. Epub 2007 Dec 11.
2
Lamotrigine in pregnancy: clearance, therapeutic drug monitoring, and seizure frequency.
Neurology. 2008 May 27;70(22 Pt 2):2130-6. doi: 10.1212/01.wnl.0000289511.20864.2a. Epub 2007 Nov 28.
3
Pharmacokinetics of levetiracetam during pregnancy, delivery, in the neonatal period, and lactation.
Epilepsia. 2007 Jun;48(6):1111-6. doi: 10.1111/j.1528-1167.2007.01032.x. Epub 2007 Mar 22.
4
Levetiracetam in pregnancy: preliminary experience from the UK Epilepsy and Pregnancy Register.
Neurology. 2006 Nov 28;67(10):1876-9. doi: 10.1212/01.wnl.0000244491.48937.55.
5
Valproate effects on kinetics of lamotrigine in pregnancy and treatment with oral contraceptives.
Neurology. 2006 Oct 10;67(7):1297-9. doi: 10.1212/01.wnl.0000238522.79277.9c.
6
Foetal malformations and seizure control: 52 months data of the Australian Pregnancy Registry.
Eur J Neurol. 2006 Jun;13(6):645-54. doi: 10.1111/j.1468-1331.2006.01359.x.
7
Changes in the disposition of oxcarbazepine and its metabolites during pregnancy and the puerperium.
Epilepsia. 2006 Mar;47(3):504-9. doi: 10.1111/j.1528-1167.2006.00459.x.
8
Seizure control and treatment in pregnancy: observations from the EURAP epilepsy pregnancy registry.
Neurology. 2006 Feb 14;66(3):354-60. doi: 10.1212/01.wnl.0000195888.51845.80. Epub 2005 Dec 28.
9
Ethinyl estradiol, not progestogens, reduces lamotrigine serum concentrations.
Epilepsia. 2005 Sep;46(9):1414-7. doi: 10.1111/j.1528-1167.2005.10105.x.
10
Fast and sustained efficacy of levetiracetam during titration and the first 3 months of treatment in refractory epilepsy.
Epilepsia. 2005 Aug;46(8):1304-7. doi: 10.1111/j.1528-1167.2005.04005.x.
Zotero 插件